Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06721793 · ClinicalTrials.gov registry record · NA
The Impact of a Caffeinated Sports Drink on Performance
A NA study of Dehydration and Dehydration Related to Exercise, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06721793: Completed NA study of Dehydration and Dehydration Related to Exercise, sponsored by Arizona State University.
NCT06721793 is a NA study of Dehydration and Dehydration Related to Exercise that has completed, run by Arizona State University. The registered enrollment target is 26 participants, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06721793, a NA study of Dehydration and Dehydration Related to Exercise, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Caffeine is known to enhance physical and mental performance, but few beverages combine caffeine with electrolytes and carbohydrates to enhance exercise performance. This study evaluates a caffeinated electrolyte-glucose drink's effect on endurance, strength, and cognition. Using a repeated-measures, cross-over design, 20 trained cyclists will complete one familiarization and four randomized 3-hour experimental trials (Liquid I.V.™ Energy Multiplier, Hydration Multiplier, Sugar-Free Hydration Multiplier, and water). Each trial includes 2 hours of cycling in a warm environment (32ºC), followed by strength and cognitive assessments. Cycling performance, capillary blood, urine, and expiratory gases will be collected.
Primary Outcome
Time in minutes of completion the 5 kilometer cycling time trial at the 3rd exercise bout.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT carbohydrate electrolyte drink
- DIETARY_SUPPLEMENT no-sugar electrolyte drink
- DIETARY_SUPPLEMENT Caffeinated Carbohydrate and electrolyte drink
- DIETARY_SUPPLEMENT Water (Placebo)
Study Locations (1)
Arizona
- Arizona State University - Hydration Science Lab - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-12-12 |
| Est. Completion | 2025-12-16 |
| Phase | NA |
What the finished NCT06721793 record still lists
NCT06721793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Dehydration appearing as the primary indexed condition, and to 4 interventions - of which carbohydrate electrolyte drink is the first listed.
NCT06721793 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06721793 about?
NCT06721793 is a clinical study titled "The Impact of a Caffeinated Sports Drink on Performance". Caffeine is known to enhance physical and mental performance, but few beverages combine caffeine with electrolytes and carbohydrates to enhance exercise performance. This study evaluates a caffeinated electrolyte-glucose drink's effect on endurance, strength, and cognition. Using a repeated-measures...
What is the current status of trial NCT06721793?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2025-12-12. Estimated completion is 2025-12-16.
What conditions does trial NCT06721793 study?
This clinical trial studies the following conditions: Dehydration, Dehydration Related to Exercise.
What interventions are being tested in trial NCT06721793?
The interventions under investigation include: carbohydrate electrolyte drink (DIETARY_SUPPLEMENT), no-sugar electrolyte drink (DIETARY_SUPPLEMENT), Caffeinated Carbohydrate and electrolyte drink (DIETARY_SUPPLEMENT), Water (Placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06721793?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06721793 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dehydration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06721793's enrollment target sits among peer trials
26 13th of 20 higher than 8 of 20 other Dehydration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
RECRUITING · NA
-
Efficacy of Education Versus Education Plus Prescribed Fluid Intake on Hydration Status in High School Athletes
RECRUITING · NA
-
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
RECRUITING · NA
-
Adequate Hydration and Health Outcomes
RECRUITING · NA
-
Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults
ACTIVE NOT RECRUITING · NA
-
Implementing an Intervention to Reduce Heat Stress and Chemical Exposures
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI